CEMAG Care SAS

Revolutionary non-adhesive secondary dressing effectively neutralizes unpleasant odors while absorbing exudates and releasing a pleasant cinnamon scent helping patients heal with comfort, confidence, and dignity. PARIS and NEW YORK, April 17, 2025 /PRNewswire/ -- Cemag Care, a pharmaceutical company focusing on the development of innovative solutions to address unmet medical needs, is pleased to announce its partnership with Clara Care Inc. as the exclusive U.S. launch partner for Cinesteam®, a groundbreaking non-adhesive secondary dressing designed to eliminate unpleasant odors and absorb exudates in wound management. Continue Reading Cemag_Clara Cinesteam® is a unique dressing that incorporates an absorbent layer and a sachet containing specially selected cinnamon powder. This natural ingredient is scientifically proven to adsorb unpleasant-smelling volatile compounds while imparting a subtle, natural fragrance, ensuring a more comfortable experience for patients and caregivers. The dressing's advanced composition allows the passage of air and moisture, preventing maceration and promoting a healthier healing environment. Cinesteam® was developed after extensive research, including multiple sensory perception tests and chemical analyses to identify the ideal cinnamon variety with optimal olfactory and adsorption properties. The result is a highly effective solution that not only addresses the clinical challenge of wound odor but also improves patient confidence and quality of life. "We are thrilled to collaborate with Clara Care Inc. to introduce Cinesteam® to the U.S. market," said Clémence Desjardin, Director of Operations and Business Development, at Cemag Care. "With Clara Care's dedicated nurse specialist support, expertise and leadership in the specialized wound care durable medical equipment space we are confident that this partnership will make a meaningful impact in odor and wound management." "At Clara Care, we are committed to bringing cutting-edge wound care solutions to healthcare providers and patients, and we firmly believe we can improve outcomes for patients and care teams by ensuring each patient, caregiver, and provider has the support they need to effectively use products like Cinesteam" said Everett Crosland, CEO at Clara Care Inc. "Cinesteam® represents a breakthrough in addressing a key challenge in wound care, and we are proud to be Cemag's launch partner for institutional customers and patients in the U.S." The partnership will see Cinesteam® made available through Clara Care Inc.'s extensive distribution network, across the United States, and ensuring that healthcare providers and patients across the country can benefit from this innovative dressing. For more information about Cinesteam®, please visit . To order Cinesteam, please visit . About Cemag Care Cinesteam® is a brand owned by a French pharmaceutical company based in Paris, Cemag Care, which was founded in 2016 by Dr André Ulmann. With a commitment to research and development, Cemag Care focuses on providing effective, patient-friendly treatments that improve the quality of life in wound care and women's health. About Clara Care Inc. Clara Care Inc. is a leading U.S. durable medical equipment supplier of wound care, ostomy, tracheostomy, lymphedema, urological, and diabetes supplies. Clara offers a unique, patient-centered approach to durable medical equipment supply, supporting each patient, caregiver, and care team with an assigned accredited nurse specialist to support the healing journey. Committed to improving patient outcomes, Clara Care partners with global innovators to bring groundbreaking medical technologies to the bedside. Contact: Clara Care Inc. Tel: 216-264-3699 [email protected] Cemag Care 55 Rue de Turbigo, 75003 Paris, France Tel : +33 (0)1 58 28 16 83 [email protected] SOURCE Clara Care Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

In a Month Focused on Diabetes Awareness, the Health Brand's Secondary Dressing Is Helping to Provide Comprehensive Quality of Life for Patients With DFUs FORT LAUDERDALE, Fla., Dec. 6, 2024 /PRNewswire/ -- Thursday, November 14th, was World Diabetes Day. The team at Cinesteam® are passionate supporters of the community managing diabetes. They are committed to helping manage diabetic foot ulcers (DFUs), especially in North America, where the condition is highest. Cinesteam®'s odor-control secondary dressings can be a key tool in maintaining patient quality of life. According to WHO and the Pan American Health Organization, World Diabetes Day offers "an opportunity to raise awareness about the impact of diabetes on people's health and to highlight the opportunities to strengthen the prevention, diagnosis, and treatment of diabetes." The healthcare partnership adds that this year's theme is "Breaking Barriers, Bridging Gaps" and that this puts an emphasis on "reducing the risk of diabetes and ensuring that all people diagnosed with diabetes have access to equitable, comprehensive, affordable, and quality treatment and care." One part of that care is the prevention and treatment of diabetic foot ulcers, open sores that can develop on the bottom of the foot and take a long time to heal. Studies have found that 19-34% of those managing diabetes will develop a diabetic foot ulcer at some point in their life. Once that happens, further complications can exacerbate the situation. For instance, over half of all ulcers develop infections that can damage feet, while one in five of those infections result in amputations. Infections can also lead to osteomyelitis (bone or bone marrow inflammation) in an additional 20% of individuals. Cinesteam® is committed to proper care of DFUs, especially in an easily overlooked area of quality treatment and care: odor management. "With so many other potential complications, it's easy to forget that malodor is a common complication with diabetic foot ulcers, as well," explained Clémence Desjardin, Director of Operations and Business Development at Cemag Care and a member of the Cinesteam® team. "Our secondary dressings can help patients manage these unwanted smells, improving their quality of life and helping them avoid discomfort and social isolation due to embarrassment." In a month where all eyes are on diabetes awareness, it's important to be comprehensive in that observation. Diabetes can lead to diabetic foot ulcers, and those ulcers can further degrade patient quality of life through malodors caused by infections. Cinesteam® is helping provide comprehensive treatment through odor management that can serve as a welcome addition to a patient's other diabetes treatment needs. About Cinesteam®: Cinesteam® is a brand owned by a French pharmaceutical company based in Paris, Cemag Care, which was founded in 2016 by Dr. André Ulmann. The brand is built on an innovative over-the-counter medical solution that uses a single natural ingredient (cinnamon) as a secondary dressing for those managing malodorous wounds from tumors, diabetic foot ulcers, pressure ulcers, and more. Cinesteam® effectively masks unwelcome odors and improves quality of life. (It does not heal the wound itself). The patented concept was developed from 2015 to 2019 and brought to market in Europe in 2020. NOTE: Cinesteam® is a class one medical device. Please read the instructions before use. Learn more at cinesteamcare.com and cemagcare.com. Media Contact: Clémence DESJARDIN, PhD Business Development Manager 55 rue de Turbigo – 75003 Paris – France Tel : +33 (0) 1 86 22 02 22 Mob: +33 (0) 6 63 04 32 77 Fax : +33 (0)1 73 79 35 54 email : [email protected] SOURCE Cinesteam WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

While the Health Brand Helps Manage Malodors From Pressure Injuries, Its Team Supports Public Education to Eliminate These Wounds From Forming in the First Place. FORT LAUDERDALE, Fla., Dec. 6, 2024 /PRNewswire/ -- Pressure injuries are common and often left out of the larger healthcare conversation. Worldwide Pressure Injury Prevention and Awareness Day helps bring attention to this overlooked area of the medical landscape. Cinesteam® also supports spreading awareness of this common medical complication and promoting solutions to pressure injuries. November 21st is Worldwide Pressure Injury Prevention and Awareness Day. The lengthy title is often reduced to "Stop the Pressure Day." Both names refer to an initiative by the National Pressure Injury Advisory Panel (NPIAP) to draw attention to pressure injury prevention. NPIAP's objective with this annual international awareness event is "to increase national awareness for pressure injury prevention and to educate the public on this topic." The day targets both healthcare professionals and the larger public. It is also a day that health brand Cinesteam® fully supports. "Pressure ulcers are extremely common and require greater education, both in the healthcare sector and with the wider public," said Clémence Desjardin, Director of Operations and Business Development at Cemag Care and a member of the Cinesteam® team. "Cinesteam® regularly helps patients with pressure ulcers manage malodors related to their wounds. Through these interactions, we've found that this is an area where awareness and prevention can make a major difference in reducing patient suffering and discomfort." While prevention is ideal, when pressure injuries and ulcers do form or develop infections, as is often the case, Cinesteam®'s secondary dressings are an industry-leading way to manage the resulting malodors. The cinnamon-filled sachets are formulated to adsorb VOCs emanating from a wound bed, replacing them with their own pleasant smell. Cinesteam®'s odor-control dressings are an effective way to treat the unwanted odors associated with pressure injuries. However, Desjardin and his team would rather see people prevent these avoidable injuries from forming in the first place. That's where NPIAP's efforts and Worldwide Pressure Injury Prevention and Awareness Day are making a difference. About Cinesteam®: Cinesteam® is a brand owned by a French pharmaceutical company based in Paris, Cemag Care, which was founded in 2016 by Dr. André Ulmann. The brand is built on an innovative over-the-counter medical solution that uses a single natural ingredient (cinnamon) as a secondary dressing for those managing malodorous wounds from tumors, diabetic foot ulcers, pressure ulcers, and more. Cinesteam® effectively masks unwelcome odors and improves quality of life. (It does not heal the wound itself). The patented concept was developed from 2015 to 2019 and brought to market in Europe in 2020. NOTE: Cinesteam® is a class one medical device. Please read the instructions before use. Learn more at cinesteamcare.com and cemagcare.com. Media Contact: Clémence DESJARDIN, PhD Business Development Manager 55 rue de Turbigo – 75003 Paris – France Tel: +33 (0) 1 86 22 02 22 Mob: +33 (0) 6 63 04 32 77 Fax: +33 (0)1 73 79 35 54 email: [email protected] SOURCE Cinesteam WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED